[ABCL] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
10-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -820.36%
YoY- -693.91%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 45,917 316,581 139,331 5,508 27,643 202,741 207,908 -63.56%
PBT -6,886 230,809 84,710 -24,972 -2,073 161,487 155,915 -
Tax -101 62,236 24,762 -3,592 250 44,266 39 -
NP -6,785 168,573 59,948 -21,380 -2,323 117,221 117,000 -
Tax Rate - -26.96% -29.23% - - -27.41% -0.02% -
Total Cost 52,702 148,008 79,383 26,888 29,966 85,520 90,909 -30.54%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -14.78 53.25 43.03 -388.16 -8.40 57.82 56.27 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.02 0.54 0.21 -0.08 -0.01 0.43 0.43 -
EPS Diluted -0.02 0.54 0.21 -0.08 -0.01 0.37 0.37 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.